Drug Approval | August 31, 2023
Ajanta Pharma receives USFDA for Topiramate Extended Release Capsules
Topiramate is the generic version of Supernus Pharmaceuticals’ Trokendi XR
Topiramate is the generic version of Supernus Pharmaceuticals’ Trokendi XR
KEYTRUDA is the first immunotherapy approved in the EU for the first-line treatment of this patient population
Novo Nordisk’s GLP-1 Ozempic has reported a YoY increase in revenue from $2.1 billion to $3.2 billion
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
Aims to build the largest connected healthcare ecosystem in India
The 100 surgeries conducted using robotic technology span various intricate procedures in the fields of Urology, Liver Transplantation, GI surgery, Cardiac surgeries and Gynaecology
Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer
Granules India received approval from Brazilian Health Regulatory Agency ANVISA
This product will be manufactured at Lupin's Pithampur facility in India
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
Subscribe To Our Newsletter & Stay Updated
